Skip to content

Welcome to Metabolomic Diagnostics

Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker-based diagnostic solutions for complex diseases.

Preeclampsia-02

May is Preeclampsia awareness month

About Us

Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker-based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.

This pipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.

Our Technology

Our technology combines the biomarker multiplexing capabilities of Mass Spectrometry with the company’s own informatics and statistics solutions to deliver diagnostic innovation.

We operate at the interface of translational research and commercialization. At all times, our multidisciplinary team is actively engaged with members of the clinical research community, manufacturers of mass spectrometry technology and clinical laboratories so that our mass spectrometry-based diagnostic solutions are fit-for-purpose.

News & Media

Latest News, Insights, Press Releases and Publications for Metabolomic Diagnostics

Pharma Industry Awards

November 1, 2023

We had a truly remarkable evening for Metabolomic Diagnostics, and we couldn’t be prouder to share the incredible news with…

Read More